{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T14:02:42Z","timestamp":1789567362348,"version":"build-2803163510"},"reference-count":89,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>\n                    Polyendocrine Metabolic Ovarian Syndrome (PMOS) is a complex endocrinopathy with characteristic features of hyperandrogenism, ovulatory dysfunction, insulin resistance, and obesity, accompanied by other associated metabolic conditions, such as chronic inflammation, oxidative stress, and dyslipidemia. Currently available treatment options are metformin and thiazolidinediones, which address only the individual symptoms but associated with adverse side effects and variable outcomes. Therefore, the establishment of multi-targeted therapeutic advances remains elusive in managing the multifactorial complications of PMOS. Intriguingly, diosgenin, a steroidal sapogenin moiety abundantly present in\n                    <jats:italic>Dioscoreaceae<\/jats:italic>\n                    spp. has gained significant interest for its multimodal effects, including insulin sensitization and regulation of ovarian steroidogenesis, owing to its antioxidant, anti-inflammatory, and hypolipidemic properties. This review discusses the role of diosgenin in regulating the pathways, including PI3K\/AKT, NF-\u03baB, lipid homeostasis, and steroidogenesis, that are primarily disrupted in PMOS. In fact, a nuclear transcription factor, peroxisome proliferator-activated receptor gamma (\n                    <jats:italic>PPAR\u03b3<\/jats:italic>\n                    ), acts as an upstream element of this vital regulatory machinery. Emerging evidence suggests that targeting\n                    <jats:italic>PPAR\u03b3<\/jats:italic>\n                    with diosgenin may improve insulin resistance, granulosa cell survival, and aromatase activity. This review presents the available preclinical and clinical evidence, as well as the challenges associated with the delivery, bioavailability, and future translational aspects of diosgenin in the management of PMOS. In summary, diosgenin may emerge as a multi-target candidate for the treatment of PMOS; however, its clinical translation requires mechanistic validation of\n                    <jats:italic>PPAR\u03b3<\/jats:italic>\n                    -mediated signaling, addressing inconsistencies in preclinical findings, optimizing bioavailability, and conducting well-designed clinical trials to establish its safety and therapeutic efficacy.\n                  <\/jats:p>","DOI":"10.3389\/fendo.2026.1906736","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T13:04:26Z","timestamp":1789563866000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Diosgenin in polyendocrine metabolic ovarian syndrome: modulation of insulin resistance, inflammation, steroidogenesis, and metabolic dysfunction"],"prefix":"10.3389","volume":"17","author":[{"given":"Madhanraj Akilandeswari","family":"Pugalendhi","sequence":"first","affiliation":[{"name":"School of Bio Sciences and Technology (SBST), Vellore Institute of Technology","place":["Vellore, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devaraj","family":"Sankarganesh","sequence":"additional","affiliation":[{"name":"School of Bio Sciences and Technology (SBST), Vellore Institute of Technology","place":["Vellore, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(26)00717-8","article-title":"Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process","volume":"407","author":"Teede","year":"2026","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/nrdp.2016.57","article-title":"Polycystic ovary syndrome","volume":"10","author":"Stener-Victorin","year":"2024","journal-title":"Nat Rev Dis Primers"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1569694","article-title":"Evolving global trends in PCOS burden: a three-decade analysis (1990\u20132021) with projections to 2036 among adolescents and young adults","volume":"16","author":"Wang","year":"2025","journal-title":"Front Endocrinol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/2314808X.2025.2554517","article-title":"Pharmacotherapeutic importance of phytoconstituents in the management of polycystic ovary syndrome (PCOS) and associated complications","volume":"12","author":"Chaudhary","year":"2025","journal-title":"Egypt J Basic Appl Sci"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/s12144-025-07435-5","article-title":"The current landscape of mental health challenges in women with PCOS: a narrative review","volume":"44","author":"Khan","year":"2025","journal-title":"Curr Psychol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijgo.2005.10.015","article-title":"Time of initiation of clomiphene citrate and pregnancy rate in polycystic ovarian syndrome","volume":"93","author":"Dehbashi","year":"2006","journal-title":"Int J Gynecol Obstet"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2008.03369.x","article-title":"Clomiphene citrate, metformin or both as first-step approach in treating anovulatory infertility in patients with polycystic ovary syndrome (PCOS): a systematic review of head-to-head randomized controlled studies and meta-analysis","volume":"70","author":"Palomba","year":"2009","journal-title":"Clin Endocrinol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.4103\/0974-1208.97789","article-title":"A prospective randomized trial comparing the efficacy of letrozole and clomiphene citrate in induction of ovulation in polycystic ovarian syndrome","volume":"5","author":"Roy","year":"2012","journal-title":"J Hum Reprod Sci"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dei289","article-title":"Metabolic and ovarian effects of rosiglitazone treatment for 12 weeks in insulin-resistant women with polycystic ovary syndrome","volume":"21","author":"Cataldo","year":"2006","journal-title":"Hum Reprod"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-031737","article-title":"Effect of the insulin sensitizer pioglitazone on insulin resistance, hyperandrogenism, and ovulatory dysfunction in women with polycystic ovary syndrome","volume":"89","author":"Brettenthaler","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"B11","article-title":"The endocrine system: an overview","volume":"22","author":"Hiller-Sturmh\u00f6fel","year":"1998","journal-title":"Alcohol Health Res World"},{"key":"B12","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1210\/er.2015-1104","article-title":"The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited","volume":"37","author":"Rosenfield","year":"2016","journal-title":"Endocr Rev"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2020.113540","article-title":"Upregulation of Cyp19a1 and PPAR-\u03b3 in ovarian steroidogenic pathway by Ficus religiosa: a potential cure for polycystic ovary syndrome","volume":"267","author":"Suriyakalaa","year":"2021","journal-title":"J Ethnopharmacol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/S0303-7207(02)00107-7","article-title":"Reproductive system: aromatase and estrogens","volume":"193","author":"Carreau","year":"2002","journal-title":"Mol Cell Endocrinol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1210\/en.2004-1046","article-title":"Activation of peroxisome proliferator-activated receptor-\u03b3 and retinoid X receptor inhibits aromatase transcription via nuclear factor-\u03baB","volume":"146","author":"Fan","year":"2005","journal-title":"Endocrinology"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/4714914","article-title":"Impact of phytochemicals on PPAR receptors: implications for disease treatments","volume":"2022","author":"Enayati","year":"2022","journal-title":"PPAR Res"},{"key":"B17","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s13679-025-00612-4","article-title":"The many facets of PPAR-\u03b3 agonism in obesity and associated comorbidities: benefits, risks, challenges, and future directions","volume":"14","author":"Kounatidis","year":"2025","journal-title":"Curr Obes Rep"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1065243","article-title":"Advancements in lead therapeutic phytochemicals for polycystic ovary syndrome: a review","volume":"13","author":"Luo","year":"2023","journal-title":"Front Pharmacol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph20156534","article-title":"The effects of plant-derived phytochemical compounds and phytochemical-rich diets on females with polycystic ovarian syndrome: a scoping review of clinical trials","volume":"20","author":"Chavez","year":"2023","journal-title":"Int J Environ Res Public Health"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s12272-022-01417-y","article-title":"Effects of phytoestrogens on reproductive organ health","volume":"45","author":"Swathi Krishna","year":"2022","journal-title":"Arch Pharm Res"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s00253-020-11055-3","article-title":"Biotechnological strategies for the sustainable production of diosgenin from Dioscorea spp","volume":"105","author":"Nazir","year":"2021","journal-title":"Appl Microbiol Biotechnol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-016-0684-y","article-title":"Preparation and evaluation of diosgenin nanocrystals to improve oral bioavailability","volume":"18","author":"Liu","year":"2017","journal-title":"AAPS PharmSciTech"},{"key":"B23","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.domaniend.2019.04.002","article-title":"The phytoestrogen, diosgenin, directly stimulates ovarian cell functions in two farm animal species","volume":"69","author":"Sirotkin","year":"2019","journal-title":"Domest Anim Endocrinol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s12098-023-04678-7","article-title":"Hyperandrogenism","volume":"90","author":"Yadav","year":"2023","journal-title":"Indian J Pediatr"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2021.07.1203","article-title":"Oxidative stress promotes hyperandrogenism by reducing sex hormone-binding globulin in polycystic ovary syndrome","volume":"116","author":"Sun","year":"2021","journal-title":"Fertil Steril"},{"key":"B26","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s00404-024-07897-1","article-title":"Hyperandrogenism in polycystic ovary syndrome and adrenal hyperplasia: finding differences to make a specific diagnosis","volume":"311","author":"Unfer","year":"2025","journal-title":"Arch Gynecol Obstet"},{"key":"B27","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12958-016-0203-8","article-title":"Effects of hyperandrogenism on metabolic abnormalities in patients with polycystic ovary syndrome: a meta-analysis","volume":"14","author":"Yang","year":"2016","journal-title":"Reprod Biol Endocrinol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.111270","article-title":"Diosgenin alters LPS-induced macrophage polarization by activating PPAR\u03b3\/NF-\u03baB signaling pathway","volume":"126","author":"Xiang","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s43042-025-00731-6","article-title":"Significant association of hyperandrogenism and insulin resistance with the epigenetic alterations in PPARG1 gene in granulosa cells of PCOS females","volume":"26","author":"Dashti","year":"2025","journal-title":"Egypt J Med Hum Genet"},{"key":"B30","doi-asserted-by":"publisher","first-page":"45","DOI":"10.14715\/cmb\/2021.67.5.6","article-title":"Changes in inflammatory factors, oxidative stress, glucose and lipid metabolism, and insulin resistance in patients with polycystic ovary syndrome","volume":"67","author":"Zhong","year":"2021","journal-title":"Cell Mol Biol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.steroids.2012.08.005","article-title":"Serum asymmetric dimethylarginine, apelin, and tumor necrosis factor-\u03b1 levels in non-obese women with polycystic ovary syndrome","volume":"77","author":"Choi","year":"2012","journal-title":"Steroids"},{"key":"B32","article-title":"How were stress family and INSR (insulin receptor) expression in polycystic ovary syndrome (PCOS) insulin resistant in Madurese tribe?: Indonesia","volume":"12","author":"Suhron","year":"2021","journal-title":"Syst Rev Pharm"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/719050","article-title":"Polycystic ovary syndrome, insulin resistance, and obesity: navigating the pathophysiologic labyrinth","volume":"2014","author":"Rojas","year":"2014","journal-title":"Int J Reprod Med"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.metop.2021.100123","article-title":"PCOS and nutritional approaches: differences between lean and obese phenotype","volume":"12","author":"Barrea","year":"2021","journal-title":"Metab Open"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0292623","article-title":"Lean mass and associated factors in women with PCOS with different phenotypes","volume":"18","author":"Fighera","year":"2023","journal-title":"PLoS One"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.steroids.2011.12.003","article-title":"Inflammation in polycystic ovary syndrome: underpinning of insulin resistance and ovarian dysfunction","volume":"77","author":"Gonz\u00e1lez","year":"2012","journal-title":"Steroids"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/s41401-023-01128-0","article-title":"Serum granulosa cell-derived TNF-\u03b1 promotes inflammation and apoptosis of renal tubular cells and PCOS-related kidney injury through NF-\u03baB signaling","volume":"44","author":"Ye","year":"2023","journal-title":"Acta Pharmacol Sin"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2007.07.003","article-title":"Obesity, depression, and chronic low-grade inflammation in women with polycystic ovary syndrome","volume":"22","author":"Benson","year":"2008","journal-title":"Brain Behav Immun"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-014-3199-3","article-title":"The effect of obesity on inflammatory markers in patients with PCOS: a BMI-matched case-control study","volume":"290","author":"Keskin Kurt","year":"2014","journal-title":"Arch Gynecol Obstet"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1186\/1755-7682-5-2","article-title":"Neutrophil lymphocyte ratio as a measure of systemic inflammation in prevalent chronic diseases in Asian population","volume":"5","author":"Imtiaz","year":"2012","journal-title":"Int Arch Med"},{"key":"B41","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ejogrb.2015.06.022","article-title":"Obesity and inflammatory biomarkers in women with polycystic ovary syndrome","volume":"192","author":"Shen","year":"2015","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-017-4429-2","article-title":"Polycystic ovary syndrome, adipose tissue and metabolic syndrome","volume":"296","author":"Delitala","year":"2017","journal-title":"Arch Gynecol Obstet"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.537809","article-title":"Circulating adipokine levels in nonobese women with polycystic ovary syndrome and in nonobese control women: a systematic review and meta-analysis","volume":"11","author":"Lin","year":"2021","journal-title":"Front Endocrinol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1210\/en.2012-1424","article-title":"Chemerin, a novel regulator of follicular steroidogenesis and its potential involvement in polycystic ovarian syndrome","volume":"153","author":"Wang","year":"2012","journal-title":"Endocrinology"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-017-0650-x","article-title":"The association between polycystic ovary syndrome, obesity, and the serum concentration of adipokines","volume":"40","author":"Behboudi-Gandevani","year":"2017","journal-title":"J Endocrinol Invest"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v10.i30.10840","article-title":"Role of visfatin in obesity-induced insulin resistance","volume":"10","author":"Abdalla","year":"2022","journal-title":"World J Clin cases"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00572.2004","article-title":"Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action","volume":"290","author":"Yang","year":"2006","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B48","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1210\/clinem\/dgad356","article-title":"Adipose tissue dysfunction in polycystic ovary syndrome","volume":"109","author":"Bril","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.892125","article-title":"The lipid profiles in different characteristics of women with PCOS and the interaction between dyslipidemia and metabolic disorder states: a retrospective study in Chinese population","volume":"13","author":"Guo","year":"2022","journal-title":"Front Endocrinol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.steroids.2011.12.002","article-title":"Dyslipidemia in PCOS","volume":"77","author":"Wild","year":"2012","journal-title":"Steroids"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1091147","article-title":"Insulin resistance, autophagy and apoptosis in patients with polycystic ovary syndrome: association with PI3K signaling pathway","volume":"13","author":"Tong","year":"2022","journal-title":"Front Endocrinol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s13048-026-02032-x","article-title":"Unveiling the role of the PI3K\/Akt signaling pathway in follicular development and non-malignant ovarian dysfunction: a comprehensive reivew","volume":"19","author":"He","year":"2026","journal-title":"J Ovarian Res"},{"key":"B53","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1186\/s12905-022-01994-6","article-title":"Up-regulation of miR-133a-3p promotes ovary insulin resistance on granulosa cells of obese PCOS patients via inhibiting PI3K\/AKT signaling","volume":"22","author":"Yang","year":"2022","journal-title":"BMC Womens Health"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11357-009-9095-2","article-title":"Chronic 17\u03b2-estradiol treatment improves skeletal muscle insulin signaling pathway components in insulin resistance associated with aging","volume":"32","author":"Moreno","year":"2010","journal-title":"Age"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-022-04587-x","article-title":"Impairment of insulin signaling pathway PI3K\/Akt\/mTOR and insulin resistance induced AGEs on diabetes mellitus and neurodegenerative diseases: a perspective review","volume":"478","author":"Ramasubbu","year":"2023","journal-title":"Mol Cell Biochem"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.117251","article-title":"Esculin ameliorates obesity-induced insulin resistance by improving adipose tissue remodeling and activating the IRS1\/PI3K\/AKT\/GLUT4 pathway","volume":"319","author":"Yang","year":"2024","journal-title":"J Ethnopharmacol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1248\/cpb.c24-00313","article-title":"Diosgenin alleviates obesity-induced insulin resistance by modulating PI3K\/Akt signaling pathway in mice fed a high-fat diet","volume":"72","author":"Oh","year":"2024","journal-title":"Chem Pharm Bull"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11102081","article-title":"Carica papaya reduces muscle insulin resistance via IR\/GLUT4 mediated signaling mechanisms in high fat diet and streptozotocin-induced type-2 diabetic rats","volume":"11","author":"Roy","year":"2022","journal-title":"Antioxidants"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.200900609","article-title":"Diosgenin present in fenugreek improves glucose metabolism by promoting adipocyte differentiation and inhibiting inflammation in adipose tissues","volume":"54","author":"Uemura","year":"2010","journal-title":"Mol Nutr Food Res"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jafc.5c07412","article-title":"Diosgenin ameliorates insulin resistance in high-fat diet-induced metabolic dysfunction-associated steatotic liver disease rats via the adiponectin\/ADIPOR1\/APPL1 pathway","volume":"73","author":"Sun","year":"2025","journal-title":"J Agric Food Chem"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2024.1280100","article-title":"Fenugreek derived diosgenin as an emerging source for diabetic therapy","volume":"11","author":"Tak","year":"2024","journal-title":"Front Nutr"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2025.11.053","article-title":"Diosgenin activates ER\u03b1-dependent PI3K\/AKT\/GSK3\u03b2 signaling to enhance brain-derived serotonin and alleviate postmenopausal bone loss","volume":"86","author":"Chen","year":"2026","journal-title":"J Adv Res"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2025.02.072","article-title":"Chronic inflammation response as a key factor in polycystic ovary syndrome among patients with bipolar disorder","volume":"377","author":"Liu","year":"2025","journal-title":"J Affect Disord"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S355677","article-title":"Diosgenin modulates oxidative stress and inflammation in high-fat diet-induced obesity in mice","volume":"15","author":"Khateeb","year":"2022","journal-title":"Diabetes Metab Syndr Obes"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1007\/s13224-023-01897-y","article-title":"Evaluation of CRP\/albumin ratio in polycystic ovarian syndrome","volume":"74","author":"Upadhyay","year":"2023","journal-title":"J Obstet Gynaecol India"},{"key":"B66","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s13098-023-01155-1","article-title":"Effect of C-reactive protein deficiency on insulin resistance reversal in rats with polycystic ovary syndrome through augmented leptin action","volume":"15","author":"Li","year":"2023","journal-title":"Diabetol Metab Syndr"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3390\/metabo13010096","article-title":"Phytochemicals and regulation of NF-\u03baB in inflammatory bowel diseases: an overview of in vitro and in vivo effects","volume":"13","author":"Laurindo","year":"2023","journal-title":"Metabolites"},{"key":"B68","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.intimp.2019.01.047","article-title":"Diosgenin ameliorates testicular damage in streptozotocin-diabetic rats through attenuation of apoptosis, oxidative stress, and inflammation","volume":"70","author":"Khosravi","year":"2019","journal-title":"Int Immunopharmacol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s13668-023-00451-6","article-title":"The effect on inflammation of adherence to the Mediterranean diet in polycystic ovary syndrome","volume":"12","author":"\u00c7\u0131tar Daz\u0131ro\u011flu","year":"2023","journal-title":"Curr Nutr Rep"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1530\/REP-22-0152","article-title":"Oxidative stress and reproductive function: oxidative stress in polycystic ovary syndrome","volume":"164","author":"Rudnicka","year":"2022","journal-title":"Reproduction"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2012.06.038","article-title":"Beneficial role of diosgenin on oxidative stress in aorta of streptozotocin induced diabetic rats","volume":"691","author":"Pari","year":"2012","journal-title":"Eur J Pharmacol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s12866-024-03329-x","article-title":"Characterization of the gut microbiota in polycystic ovary syndrome with dyslipidemia","volume":"24","author":"Yang","year":"2024","journal-title":"BMC Microbiol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.9734\/AJBGMB\/2023\/v15i3333","article-title":"Understanding the relationship between polycystic ovarian syndrome (PCOS) and dyslipidemia","volume":"15","author":"Amadi","year":"2023","journal-title":"Asian J Biochem Genet Mol Biol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3945\/jn.110.125591","article-title":"Diosgenin, the main aglycon of fenugreek, inhibits LXR\u03b1 activity in HepG2 cells and decreases plasma and hepatic triglycerides in obese diabetic mice","volume":"141","author":"Uemura","year":"2011","journal-title":"J Nutr"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2025.106773","article-title":"FSH, LH, lipid and adipokines in polycystic ovary syndrome: clinical biochemistry insights for diagnosis and management","volume":"251","author":"Merza","year":"2025","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1007\/s12247-025-10339-3","article-title":"Diosgenin-loaded silver nanoparticles mitigate obesity-related metabolic dysfunction: an integrative analysis of biochemical, transcriptional, and molecular docking evidence","volume":"21","author":"Mohamed","year":"2026","journal-title":"J Pharm Innov"},{"key":"B77","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s12010-016-2084-x","article-title":"Comparative analysis of proteins with stimulating activity on ovarian estradiol biosynthesis from four different Dioscorea species in vitro using both phenotypic and target-based approaches: implication for treating menopause","volume":"180","author":"Lu","year":"2016","journal-title":"Appl Biochem Biotechnol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.toxlet.2016.11.001","article-title":"Effects of PCB 126 and PCB 153 on secretion of steroid hormones and mRNA expression of steroidogenic genes (STAR, HSD3B, CYP19A1) and estrogen receptors (ER\u03b1, ER\u03b2) in prehierarchical chicken ovarian follicles","volume":"264","author":"Sechman","year":"2016","journal-title":"Toxicol Lett"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.624112","article-title":"PPARgamma in metabolism, immunity, and cancer: unified and diverse mechanisms of action","volume":"12","author":"Hernandez-Quiles","year":"2021","journal-title":"Front Endocrinol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2010.07.1083","article-title":"Peroxisome proliferator-activated receptor gamma and early folliculogenesis during an acute hyperandrogenism condition","volume":"95","author":"Faut","year":"2011","journal-title":"Fertil Steril"},{"key":"B81","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.theriogenology.2024.10.010","article-title":"Effects of PPARG on the proliferation, apoptosis, and estrogen secretion in goat granulosa cells","volume":"231","author":"Zhao","year":"2025","journal-title":"Theriogenology"},{"key":"B82","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.pharep.2018.09.009","article-title":"Treatment with the synthetic PPARG ligand pioglitazone ameliorates early ovarian alterations induced by dehydroepiandrosterone in prepubertal rats","volume":"71","author":"Velez","year":"2019","journal-title":"Pharmacol Rep"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2013.08.014","article-title":"PPAR's and diosgenin: a chemico biological insight in NIDDM","volume":"206","author":"Sangeetha","year":"2013","journal-title":"Chem Biol Interact"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2015.09.015","article-title":"Effect of diosgenin on metabolic dysfunction: role of ER\u03b2 in the regulation of PPAR\u03b3","volume":"289","author":"Wang","year":"2015","journal-title":"Toxicol Appl Pharmacol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-014-2152-x","article-title":"Trigonelline and diosgenin attenuate ER stress, oxidative stress-mediated damage in pancreas and enhance adipose tissue PPAR\u03b3 activity in type 2 diabetic rats","volume":"396","author":"Tharaheswari","year":"2014","journal-title":"Mol Cell Biochem"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2025.e42582","article-title":"Exploring the molecular mechanism of Dioscorea alata L. for the treatment of menstrual disorders using network pharmacology and molecular docking","volume":"11","author":"Silambarasan","year":"2025","journal-title":"Heliyon"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1111\/ppl.70621","article-title":"Reprogramming of diosgenin-specialized metabolism in plants and its medicinal applications","volume":"177","author":"Mandal","year":"2025","journal-title":"Physiol Plant"},{"key":"B88","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s40001-017-0285-6","article-title":"Observation of the influences of diosgenin on aging ovarian reserve and function in a mouse model","volume":"22","author":"Shen","year":"2017","journal-title":"Eur J Med Res"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.3390\/nu17233695","article-title":"The combination of diosgenin, vitamin D, and \u03b1-lactalbumin normalizes the menstrual cycle in women with PCOS of phenotype D: a pilot clinical study","volume":"17","author":"Russo","year":"2025","journal-title":"Nutrients"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1906736\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T13:04:27Z","timestamp":1789563867000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1906736\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,16]]},"references-count":89,"alternative-id":["10.3389\/fendo.2026.1906736"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1906736","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,16]]},"article-number":"1906736"}}